Related Experiment Video
Updated: Aug 9, 2026
03:22
Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases
Published on: March 1, 2024
A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in
Preston R Miller1, Matthew S Partrick, J Jason Hoth
1Department of Surgery, Wake Forest University Bowman Gray School of Medicine, Winston-Salem, NC 27157, USA. pmiller@wfubmc.edu
The Journal of Trauma
|April 14, 2006
Summary
Practice-based learning (PBL) successfully guided the development of a ventilator-associated pneumonia (VAP) treatment algorithm, improving empiric antibiotic coverage and patient outcomes. This approach demonstrates PBL
Area of Science:
- Medical Education
- Infectious Disease Management
- Critical Care Medicine
Background:
- Practice-based learning (PBL) is a core competency in resident education.
- Developing effective PBL strategies for daily clinical practice presents challenges.
- This study aimed to apply PBL to improve patient care through a VAP treatment algorithm.
Purpose of the Study:
- To describe the successful application of practice-based learning (PBL) in improving patient care.
- To develop an evidence-based algorithm for the empiric therapy of ventilator-associated pneumonia (VAP).
- To assess the impact of the VAP algorithm on antibiotic coverage and patient outcomes.
Main Methods:
- Algorithm development involved two phases: reviewing VAP microbiology and timing, then creating and implementing an empiric antibiotic coverage strategy.
- Phase 1 analyzed 110 VAP cases from 2000-2001 to identify infection patterns.
- Phase 2 implemented an algorithm from 2002-2003, evaluating 186 VAP cases for coverage adequacy and outcomes.
Main Results:
- Microbiology analysis revealed a significant increase in nosocomial pathogens after postinjury day 7 (47% vs. 19%).
- The VAP algorithm improved adequate initial empiric antibiotic coverage from 74% to 83% (p=0.05).
- Mortality showed a trend toward decrease, from 21% to 13% (p=0.1).
Conclusions:
- Implementing an institution-specific VAP treatment algorithm based on PBL principles achieved over 80% adequate initial empiric coverage.
- PBL facilitates practice alteration based on local infection patterns and outcomes, enhancing patient care.
- This study highlights the potential of PBL to optimize VAP management and reduce mortality.
Related Concept Videos
01:28Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
01:22Healthcare Associated Infections II: Preventive Measures
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
01:30Pneumonia III: Complications and Assessment
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
01:14Atypical Pneumonia
Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
01:24Automated Microbial Diagnostics
Automated diagnostic analyzers have transformed clinical microbiology by providing rapid and reliable methods for pathogen identification and antibiotic susceptibility testing. Among these systems, the Vitek 2 is widely used because it automates the traditionally labor-intensive processes of microbial identification (ID) and antibiotic susceptibility testing (AST), delivering standardized and timely results that are essential for effective patient care.Microbial Identification with ID CardsThe...
01:29Pneumonia I: Introduction
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...